Ares Financial Consulting’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Ares Financial Consulting's AMGN Position: Q3 2026 in Review
Ares Financial Consulting increased its Amgen (AMGN) stake by 2.6% in Q3 2026, buying an estimated $3.19K and bringing the position to 318 shares worth $134K. The position accounts for 0.09% of the portfolio, ranked #117.
Ares Financial Consulting first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,039 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Ares Financial Consulting held 318 shares of Amgen worth $134K as of Q3 2026.
- Ares Financial Consulting bought 8 Amgen shares in Q3 2026, an estimated $3.19K.
- Amgen made up 0.09% of Ares Financial Consulting's portfolio in Q3 2026, its #117 holding.
- Ares Financial Consulting first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- 2,039 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.